Our pursuit and company goal is to "Always satisfy our customer requirements". We continue to develop and design superior quality products for both our old and new customers and achieve a win-win prospect for our clients as well as us for Non-Expression Vector Supplier, Real-Time Rt-Pcr Supplier, Smart-Seq Supplier, Stubby Adapter Suppliers, Monkeypox Test Kits Factories.We sincerely welcome you come to visit us. Hope we have good cooperation in the future. The product will supply to all over the world, such as Europe, America, Australia, El Salvador ,Estonia ,United Arab Emirates ,We take measure at any expense to achieve essentially the most up-to-date equipment and approaches. The packing of nominated brand is our a further distinguishing feature. The items to assure years of trouble-free service has attracted a great deal customers. The solutions are obtainable in improved designs and richer assortment, they're created scientifically of purely raw supplies. It readily available in a variety of designs and specifications for your selection. The most recent kinds are a great deal better than the preceding one particular and they are quite popular with lots of prospects.
This kit is designed for the detection of host cell protein residues in process samples of biologics (such as antibodies, recombinant proteins, vaccines, etc.) expressed in CHO cell lines.
T7 RNA Polymerase (T7 RNA polymerase) is a DNA-dependent 5'→3' RNA polymerase that recognizes the T7 promoter sequence with high specificity ,can be used for transcriptional synthesis of mRNA in IVT.
The dsRNA sequence synthesized by UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
The dsRNA sequence synthesized by Pseudouridine-UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
The dsRNA sequence synthesized by N1-me-pseudo-UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
A next-generation T7 RNA polymerase engineered to minimize dsRNA byproducts by up to 100×, enabling safer and more efficient mRNA therapeutics.
